Research Analysts Issue Forecasts for TriMas FY2024 Earnings

TriMas Co. (NASDAQ:TRS) – Analysts at Zacks Research increased their FY2024 EPS estimates for TriMas in a research report issued to clients and investors on Monday, January 27th. Zacks Research analyst M. Das now forecasts that the industrial products company will post earnings per share of $1.71 for the year, up from their prior estimate of $1.70. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q2 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.48 EPS, FY2025 earnings at $2.04 EPS, Q1 2026 earnings at $0.50 EPS, Q2 2026 earnings at $0.53 EPS and Q3 2026 earnings at $0.56 EPS.

TRS has been the topic of several other research reports. StockNews.com upgraded TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th. BWS Financial reiterated a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Thursday, January 23rd.

TriMas Trading Down 0.7 %

Shares of NASDAQ TRS opened at $24.30 on Thursday. The company’s fifty day moving average is $24.95 and its 200-day moving average is $25.43. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. The stock has a market cap of $985.85 million, a price-to-earnings ratio of 37.97 and a beta of 0.67. TriMas has a twelve month low of $22.24 and a twelve month high of $28.51.

TriMas (NASDAQ:TRS) last released its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.14). The company had revenue of $229.36 million during the quarter, compared to analyst estimates of $239.33 million. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.57 EPS.

Institutional Trading of TriMas

A number of institutional investors have recently made changes to their positions in TRS. Intech Investment Management LLC bought a new stake in shares of TriMas during the 3rd quarter worth approximately $269,000. Paloma Partners Management Co acquired a new stake in shares of TriMas in the third quarter valued at approximately $293,000. XTX Topco Ltd bought a new position in shares of TriMas during the 3rd quarter worth approximately $371,000. Algert Global LLC increased its holdings in shares of TriMas by 4.2% during the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after acquiring an additional 639 shares during the last quarter. Finally, Inspire Investing LLC raised its stake in TriMas by 17.4% in the 3rd quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock valued at $412,000 after acquiring an additional 2,389 shares during the period. Institutional investors own 99.42% of the company’s stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.